HIGHLIGHTS
- who: Shinya Tsuboi from the Department of Pharmacy, Nihon University Itabashi Hospital, u2011, Oyaguchikamicho, Itabashi City, Tokyo, u20118610, Japan have published the research: Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience, in the Journal: (JOURNAL)
- what: The authors aimed to determine the risk factors for PIBP in real-world clinical practice. To determine the cutoff value in the study more precisely, the authors replaced the cutoff value of 45 years with 55 years, which was calculated using ROC analysis.
SUMMARY
Currently, granulocyte . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.